Citations for
1AURKA, MAPK8, MAPK9, WDR62
Opposing roles for JNK and Aurora A in regulating the association of WDR62 with spindle microtubules.
Lim NR, Yeap YY, Zhao TT, Yip YY, Wong SC, Xu D, Ang CS, Williamson NA, Xu Z, Bogoyevitch MA, Ng DC.
J Cell Sci 128(3):527-40. 2015
2IRS2, MAPK8, MAPK9, MAPK9
JNK3 maintains expression of the insulin receptor substrate 2 (IRS2) in insulin-secreting cells: functional consequences for insulin signaling.
Abdelli S, Bonny C.
PLoS One 7(5):e35997. doi: 10.1371/journal.pone.0035997. Epub 2012 May 1. 2012
3MAPK8, MAPK9
Requirement of c-Jun NH(2)-terminal kinase for Ras-initiated tumor formation.
Cellurale C, Sabio G, Kennedy NJ, Das M, Barlow M, Sandy P, Jacks T, Davis RJ.
Mol Cell Biol 31(7):1565-76. Epub 2011 Jan 31. 2011
4MAPK9
JNK2 participates in spindle assembly during mouse oocyte meiotic maturation.
Huang X, Tong JS, Wang ZB, Yang CR, Qi ST, Guo L, Ouyang YC, Quan S, Sun QY, Qi ZQ, Huang RX, Wang HL.
Microsc Microanal 17(2):197-205. Epub 2011 Jan 31. 2011
5EPS8, MAPK9
c-Jun N-terminal kinase 2 (JNK2) enhances cell migration through epidermal growth factor substrate 8 (EPS8).
Mitra S, Lee JS, Cantrell M, Van den Berg CL.
J Biol Chem 286(17):15287-97. Epub 2011 Feb 28. 2011
6MAPK9
Molecular cloning and characterization of novel human JNK2 (MAPK9) transcript variants that show different stimulation activities on AP-1.
Wang P, Xiong Y, Ma C, Shi T, Ma D.
BMB Rep 43(11):738-43. 2010
7MAPK10, MAPK9
Hippocampal c-Jun-N-terminal kinases serve as negative regulators of associative learning.
Sherrin T, Blank T, Hippel C, Rayner M, Davis RJ, Todorovic C.
J Neurosci 30(40):13348-61. 2010
8MAPK9
c-Jun NH2-terminal kinase-2 mediates osmotic stress-induced tight junction disruption in the intestinal epithelium.
Samak G, Suzuki T, Bhargava A, Rao RK.
Am J Physiol Gastrointest Liver Physiol 299(3):G572-84. Epub 2010 Jul 1. 2010
9MAPK8, MAPK9
JNK1 and JNK2 differently regulate IL-12 production in THP-1 macrophage cells.
Utsugi M, Dobashi K, Ono A, Ishizuka T, Hisada T, Koga Y, Shimizu Y, Kawata T, Matsuzaki S, Aoki H, Kamide Y, Mori M.
Cytokine 51(2):127-31. Epub 2010 May 18. 2010
10MAPK9
The c-Jun NH2-terminal kinase 2 plays a dominant role in human epidermal neoplasia.
Ke H, Harris R, Coloff JL, Jin JY, Leshin B, Miliani de Marval P, Tao S, Rathmell JC, Hall RP, Zhang JY.
Cancer Res 70(8):3080-8. Epub 2010 Mar 30. 2010
11MAPK8, MAPK9
Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.
Gancz D, Donin N, Fishelson Z.
Mol Immunol 47(2-3):310-7. Epub 2009 Oct 27. 2009
12MAPK9
Constitutive activity of JNK2 alpha2 is dependent on a unique mechanism of MAPK activation.
Nitta RT, Chu AH, Wong AJ.
J Biol Chem 283(50):34935-45. Epub 2008 Oct 21. 2008
13ALDH1L1, MAPK8, MAPK9
Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway.
Oleinik NV, Krupenko NI, Krupenko SA.
Oncogene 26(51):7222-30. Epub 2007 May 21.PMID: 17525747 2007
14RP1, MAPK8, MAPK9, MAPK10, MAP2K4 , MAP2, JUN
Distinct gene expression profiles and reduced JNK signaling in retinitis pigmentosa caused by RP1 mutations.
Liu J, Huang Q, Higdon J, Liu W, Xie T, Yamashita T, Cheon K, Cheng C, Zuo J.
Hum Mol Genet 14(19):2945-58. Epub 2005 Aug 26. 2005
15MAPK8, MAPK9
The c-Jun NH2-terminal kinase is essential for epidermal growth factor expression during epidermal morphogenesis.
Weston CR, Wong A, Hall JP, Goad ME, Flavell RA, Davis RJ.
Proc Natl Acad Sci U S A 101(39):14114-9. Epub 2004 Sep 16. 2004
16MAPK9, PDB3, SQSTM1
Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.
Laurin N, Brown JP, Morissette J, Raymond V.
Am J Hum Genet 70(6):1582-8. 2002